-
23 July 2025 09:30:23
- Source: Sharecast

23 July 2025
Assura plc
("the Company")
Exercise of Nil Cost Options under PSP
The Company announces that on 22 July 2025, the PDMRs listed below exercised their 2022 PSP awards.
The table below shows the number of shares vesting, the number of shares sold to satisfy income tax and national insurance liabilities and the number of shares received following the sales.
|
Number of shares awarded |
Number of shares sold to satisfy income tax and national insurance liabilities |
Additional shares sold |
Number of shares after shares sold |
Jonathan Murphy |
344,426 |
161,880 |
- |
182,546 |
Jayne Cottam |
200,490 |
94,230 |
- |
106,260 |
Orla Ball |
62,964 |
29,593 |
33,371 |
- |
Rob James |
80,135 |
37,663 |
42,472 |
- |
The Remuneration Committee of Assura had agreed that sufficient shares may be sold by each PDMR to cover the arising income tax and national insurance liabilities and that Ms Ball and Mr James could sell the balances of their restricted shares in full. The relevant market price for taxation purposes is £0.5025 per share.
As a result of the above, the PDMR's shareholding and those of their connected persons is as follows:
|
Shareholding on 21 July 2025
|
Shareholding post exercise |
Jonathan Murphy |
3,335,217 |
3,517,763 |
Jayne Cottam |
960,362 |
1,066,622 |
Orla Ball |
47,060 |
47,060 |
Rob James |
37,667 |
37,667 |
Following the allotment, Mr Murphy and Ms Cottam transferred 182,546 and 106,260 shares respectively to their spouses. The total beneficial holding remains the same.
The Notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
|||||||
a) |
Name
|
Jonathan Murphy |
||||||
2 |
Reason for the notification
|
|||||||
a) |
Position/status
|
CEO |
||||||
b) |
Initial notification/ Amendment
|
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a) |
Name
|
Assura plc |
||||||
b) |
LEI
|
21380026T19N2Y52XF72 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Vesting of share awards under PSP
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
N/A |
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of shares to satisfy tax and national insurance liabilities
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Transfer of shares to spouse
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
|||||||
a) |
Name
|
Jayne Cottam |
||||||
2 |
Reason for the notification
|
|||||||
a) |
Position/status
|
CFO |
||||||
b) |
Initial notification/ Amendment
|
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a) |
Name
|
Assura plc |
||||||
b) |
LEI
|
21380026T19N2Y52XF72 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Vesting of share awards under PSP
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
N/A |
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of shares to satisfy tax and national insurance liabilities
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Transfer of shares to spouse
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
|||||||
a) |
Name
|
Orla Ball |
||||||
2 |
Reason for the notification
|
|||||||
a) |
Position/status
|
General Counsel |
||||||
b) |
Initial notification/ Amendment
|
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a) |
Name
|
Assura plc |
||||||
b) |
LEI
|
21380026T19N2Y52XF72 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Vesting of restricted share awards under PSP
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
N/A |
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of shares to satisfy tax and national insurance liabilities
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of shares
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
|||||||
a) |
Name
|
Rob James |
||||||
2 |
Reason for the notification
|
|||||||
a) |
Position/status
|
Group Development Director |
||||||
b) |
Initial notification/ Amendment
|
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a) |
Name
|
Assura plc |
||||||
b) |
LEI
|
21380026T19N2Y52XF72 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Vesting of restricted share awards under PSP
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
N/A |
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of shares to satisfy tax and national insurance liabilities
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of shares
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
22 July 2025 |
||||||
f) |
Place of the transaction
|
XLON |
For more information, please contact:
Assura plc |
Tel: 0161 515 2043 |
David Purcell, Investor Relations Director
|
Email: Investor@assura.co.uk |
FGS Global Gordon Simpson |
Tel: 0207 251 3801 Email: Assura@fgsglobal.com |
Notes to Editors
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.
A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices and has a secondary listing on the Johannesburg Stock Exchange.
At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G).
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.